Fu Haixia, Zhang Xiaohui, Xu Lanping, Liu Kaiyan, Huang Xiaojun
Peking University People's Hospital, Institute of Hematology, Beijing, China.
Clin Transplant. 2016 Feb;30(2):170-8. doi: 10.1111/ctr.12673. Epub 2015 Dec 31.
Thrombopoietin (TPO) has been identified as a key cytokine for both megakaryogenesis and thrombopoiesis. We attempt to characterize the kinetics of TPO and its correlation with megakaryocytes (MKs) ploidy distribution pattern within 60 d after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Forty-six consecutive patients undergoing allo-HSCT from October 2008 to December 2008 were included. TPO levels and ploidy distribution patterns of MKs were measured using ELISA and flow cytometric analysis, respectively. The results indicated that TPO levels and the platelet count followed opposite trends after allo-HSCT. The preconditioning TPO levels and the number of transplanted CD34(+) cells were significant predisposing factors for rapid platelet engraftment (p = 0.010 and 0.007, respectively) by multivariate analysis. There was a reduction of ploidy and an increase in immature MKs in patients with higher endogenous TPO levels (>250 pg/mL) on day 60 after allo-HSCT. Moreover, lower TPO levels (≤250 pg/mL) on day 60 after allo-HSCT were associated with significantly improved five-yr overall survival (p = 0.021) and reduced transplant-related mortality (p = 0.033). In conclusion, endogenous TPO levels may be associated with platelet recovery and have prognostic significance during allo-HSCT.
血小板生成素(TPO)已被确定为巨核细胞生成和血小板生成的关键细胞因子。我们试图描述异基因造血干细胞移植(allo-HSCT)后60天内TPO的动力学及其与巨核细胞(MKs)倍性分布模式的相关性。纳入了2008年10月至2008年12月连续接受allo-HSCT的46例患者。分别使用酶联免疫吸附测定(ELISA)和流式细胞术分析测量TPO水平和MKs的倍性分布模式。结果表明,allo-HSCT后TPO水平和血小板计数呈相反趋势。多因素分析显示,预处理时的TPO水平和移植的CD34(+)细胞数量是血小板快速植入的重要预测因素(分别为p = 0.010和0.007)。allo-HSCT后60天时,内源性TPO水平较高(>250 pg/mL)的患者中,MKs的倍性降低,未成熟MKs增加。此外,allo-HSCT后60天时较低的TPO水平(≤250 pg/mL)与显著改善的5年总生存率(p = 0.021)和降低的移植相关死亡率(p = 0.033)相关。总之,内源性TPO水平可能与血小板恢复相关,并且在allo-HSCT期间具有预后意义。